Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Mounjaro (Tirzepatide) The Game Changer Now officially licensed in Thailand Dual-action: GLP-1 and GIP receptor agonist Delivers superior appetite regulation and improved insulin sensitivity Clinical trials show up to 22.5% total body weight reduction (one of the highest across all medications) Weekly injection with flexible dosing (2.5mg15mg) Approved for Type 2 diabetes, but increasingly prescribed off-label for weight loss worldwide Unique advantage: targets two hormones , making it a potential first-choice option for patients who havent succeeded with other injectables 4
It is particularly beneficial for individuals looking to enhance their immune response, reduce oxidative stress, and promote skin health
The Pur Health's physician-supervised model provides critical advantages over medical spas, wellness centers, or mobile IV services
Consistent use over extended periods often yields better outcomes
Some patients have a threshold effect: tolerable constipation at 1.0 mg, sudden severe constipation at 1.7 mg, no further worsening at 2.4 mg
GSH, GSSG, 3-NT, 3-CT and 8-oxo-dG Figure 1 presents the relative concentrations of GSH, GSSG, 3-NT, 3-CT and 8-oxo-dG in the autism and control cerebellum, and the BA22 samples
US$ 27.16
US$ 25.51
US$ 28.28
US$ 27.24
US$ 28.73
